CME Group Inc. (NASDAQ:CME) Given Average Rating of “Hold” by Analysts

CME Group Inc. (NASDAQ:CME) has earned a consensus recommendation of “Hold” from the eighteen analysts that are currently covering the stock, Marketbeat reports. Three investment analysts have rated the stock with a sell rating, seven have issued a hold rating and eight have issued a buy rating on the company. The average 1 year price objective among analysts that have issued ratings on the stock in the last year is $287.7059.

Several analysts have recently weighed in on the company. Rothschild & Co Redburn raised their target price on CME Group from $297.00 to $300.00 and gave the company a “neutral” rating in a research note on Thursday, November 6th. Piper Sandler boosted their target price on shares of CME Group from $296.00 to $313.00 and gave the stock an “overweight” rating in a research report on Thursday, November 13th. Argus lowered their price objective on CME Group from $308.00 to $295.00 in a report on Friday, October 31st. JPMorgan Chase & Co. upped their price objective on CME Group from $252.00 to $256.00 and gave the company an “underweight” rating in a research note on Tuesday, October 14th. Finally, Deutsche Bank Aktiengesellschaft raised their price objective on CME Group from $300.00 to $310.00 and gave the stock a “buy” rating in a research note on Friday, November 14th.

Insider Transactions at CME Group

In other news, Director Harold Eugene Jr. Ford sold 1,000 shares of the stock in a transaction on Monday, November 3rd. The stock was sold at an average price of $263.53, for a total value of $263,530.00. Following the completion of the sale, the director owned 1,091 shares in the company, valued at $287,511.23. This represents a 47.82% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, insider Timothy Francis Mccourt sold 379 shares of the business’s stock in a transaction on Tuesday, September 16th. The shares were sold at an average price of $259.83, for a total transaction of $98,475.57. Following the transaction, the insider owned 9,508 shares in the company, valued at approximately $2,470,463.64. This represents a 3.83% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last ninety days, insiders sold 2,147 shares of company stock worth $562,079. Corporate insiders own 0.30% of the company’s stock.

Hedge Funds Weigh In On CME Group

Institutional investors have recently modified their holdings of the stock. Vanguard Group Inc. grew its position in CME Group by 0.4% during the 3rd quarter. Vanguard Group Inc. now owns 35,307,074 shares of the financial services provider’s stock worth $9,539,618,000 after acquiring an additional 130,698 shares during the last quarter. Geode Capital Management LLC boosted its stake in shares of CME Group by 3.6% in the 2nd quarter. Geode Capital Management LLC now owns 9,178,681 shares of the financial services provider’s stock valued at $2,524,271,000 after purchasing an additional 319,899 shares during the last quarter. Norges Bank acquired a new stake in shares of CME Group during the second quarter worth $1,571,447,000. Ameriprise Financial Inc. raised its stake in CME Group by 2.8% during the third quarter. Ameriprise Financial Inc. now owns 4,812,914 shares of the financial services provider’s stock worth $1,300,450,000 after buying an additional 130,848 shares during the last quarter. Finally, Raymond James Financial Inc. lifted its holdings in CME Group by 9.7% in the first quarter. Raymond James Financial Inc. now owns 4,113,991 shares of the financial services provider’s stock valued at $1,091,401,000 after buying an additional 363,130 shares during the period. 87.75% of the stock is owned by institutional investors.

CME Group Stock Down 0.4%

CME stock opened at $273.19 on Friday. The company has a debt-to-equity ratio of 0.12, a current ratio of 1.02 and a quick ratio of 1.02. The company’s 50 day simple moving average is $271.55 and its 200-day simple moving average is $272.85. CME Group has a 12 month low of $224.62 and a 12 month high of $290.79. The firm has a market capitalization of $98.51 billion, a PE ratio of 26.47, a P/E/G ratio of 4.28 and a beta of 0.28.

CME Group (NASDAQ:CME) last issued its quarterly earnings results on Wednesday, October 22nd. The financial services provider reported $2.68 earnings per share for the quarter, topping analysts’ consensus estimates of $2.63 by $0.05. CME Group had a return on equity of 14.61% and a net margin of 58.84%.The company had revenue of $1.54 billion for the quarter, compared to analyst estimates of $1.56 billion. During the same quarter in the prior year, the company posted $2.68 EPS. The business’s revenue for the quarter was down 3.0% compared to the same quarter last year. Equities analysts expect that CME Group will post 10.49 earnings per share for the current fiscal year.

CME Group Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, December 30th. Shareholders of record on Friday, December 12th will be given a dividend of $1.25 per share. This represents a $5.00 dividend on an annualized basis and a dividend yield of 1.8%. The ex-dividend date is Friday, December 12th. CME Group’s payout ratio is 48.45%.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.